Background and Purpose-Peripartum strokes during delivery admissions are rare but have high maternal morbidity.
M aternal stroke complicates 30 of every 100 000 pregnancies and is associated with substantial maternal morbidity and mortality. 1 Risk factors for peripartum stroke include hypertensive disorders of pregnancy (HDP), including gestational hypertension, preeclampsia, and eclampsia; chronic hypertension; migraine headaches; antiphospholipid syndrome and other thrombophilias; sickle cell disease; black race; cesarean delivery; and extremes of age. 2, 3 Multiple studies have shown an increased risk of stroke in the postpartum period compared with during the pregnancy itself. [3] [4] [5] [6] [7] However, 30% to 40% of pregnancy-associated strokes occur during the delivery admission, 2, 8 and at least 1 study found the highest risk 1 day prior and 2 days after delivery. 9 Despite known risk factors, these devastating events remain difficult to predict because of their rarity, hampering efforts to develop preventive strategies.
Infection is a novel risk factor that has emerged as an important and underrecognized trigger for stroke, particularly in young people. [10] [11] [12] Acute respiratory infections and urinary tract infections were associated with a transient increase in cardiovascular event rates including myocardial infarction and stroke in a large population-based study. 13 Several studies have found an association between infections and peripartum or postpartum stroke, 3, 14, 15 with 1 study showing a 25-fold increase in the odds of postpartum stroke in women with postpartum infections. 2 Infections have been noted as a risk factor for peripartum stroke in women with preeclampsia, 15 a subgroup that is at 5-to 6-fold higher risk for
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pregnancy-related stroke compared with women without preeclampsia. 8, 16 Interestingly, infections have also been implicated in the pathogenesis of preeclampsia; multiple studies have demonstrated a strong association between preexisting infections including Helicobacter pylori, 17 Chlamydia pneumoniae, and urinary tract infections 18, 19 and the development of preeclampsia. However, the relationship between infection and peripartum stroke in the general pregnant population is not well characterized. In particular, infection as a trigger for stroke at the time of delivery has not been described in prior studies, and there are few data on timing of infections (present on admission or hospital acquired). Furthermore, most prior studies of pregnancy-related stroke did not explore infection subtypes as a risk factor.
We hypothesized that women who had infections diagnosed at the time of delivery admission would have higher risk of stroke during their delivery hospitalization.
Methods
The data that support the findings of this study are available from the corresponding author on reasonable request.
Study Design and Population
We performed a case-control study using data from the Healthcare Cost and Utilization Project State Inpatient Database for California (2007) (2008) (2009) (2010) (2011) , Florida (2009 Florida ( -2011 , and New York (2009-2011), which includes hospital and emergency department discharge data from all nonfederal hospitals in each state. We restricted the sample to female patients aged 15 to 45 with visits coded by the major diagnostic category of 14 (pregnancy, childbirth, and the puerperium). Women with a stroke diagnosis present on admission were excluded from the analysis. Delivery admissions were selected using diagnosis-related groups for vaginal and cesarean delivery codes (Table I in  the online-only Data Supplement) . 20, 21 Diagnosis-related group codes changed in October 2007, so both sets of codes were used to select the cohort from the 2007 data sets. 22 Delivery hospitalizations with diagnostic codes for oncology and trauma based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9) were excluded from the sample. Stroke and other cerebrovascular outcomes, infections, HDP, and additional stroke risk factors were abstracted using ICD-9 codes.
Women who met our inclusion criteria and had a stroke diagnosis during the delivery admission, defined as a diagnostic ICD-9 code for stroke not present on admission, were considered cases, and were randomly matched to 3 . We chose to match on HDP status because of the concern that preeclampsia and other HDP were potentially related to both the exposure of interest (infection) and the outcome (stroke). We also conducted preplanned subgroup analyses to test whether the hypothesized relationship between infection and peripartum stroke changed based on the presence of HDP.
Exposures and Outcome of Interest
The primary exposure of interest was the presence of any infection at the time of admission, indicated by a present on admission diagnostic code modifier. Women with a new stroke diagnosis code during the delivery admission were considered cases and were matched with stroke-free controls on age, state, year of admission, and HDP status. Women with gestational hypertension or mild preeclampsia were considered to have mild HDP. Women with severe preeclampsia or eclampsia were considered to have severe HDP. HDP indicates hypertensive disorder of pregnancy.
*Data on race/ethnicity were not available for all subjects. 
Informed Consent and Approvals
Approval was obtained for the study from the Institutional Review Board of Columbia University Medical Center, and the requirement for written informed consent was waived because of the public and deidentified nature of the data.
Statistical Analysis
We compared demographics and risk factors between cases and controls using proportions for categorical variables and mean/SD for continuous variables. Crude and adjusted conditional logistic regression models were used to estimate the odds ratios and 95% confidence intervals (CIs) for the association between infections present on admission and stroke during delivery admission. We included in the adjusted models only those variables which showed a significant association both with the exposure of interest (infection) and the outcome (stroke). We performed subgroup analyses of the same variables in women without HDP, with mild HDP, and with severe HDP. All analyses were conducted using SAS statistical software (SAS version 9.4, Cary, NC). An α of 0.05 was considered significant.
Results
Of the 2 799 020 delivery admissions during the study period, 455 received a new diagnostic code for stroke during the admission and were considered cases, suggesting a cumu- (Table 2) . Women who had an infection had 1.76 (95% CI, 1.31-2.37) times the odds of a stroke diagnosis during their delivery admission compared with controls, and when adjusted for race and insurance payer status the relationship remained (odds ratio, 1.74; 95% CI, 1.29-2.35). Infection subtypes are shown in the Figure. Sepsis and genitourinary infections were more highly associated with stroke diagnoses than other types of infection: women with sepsis had 10.4 (95% CI, 2.15-50.0) times the odds of stroke diagnosis during the delivery hospitalization, and women with genitourinary infections had 2.56 (95% CI, 1.25-5.24) times the odds of stroke diagnosis after adjustment. There was no significant association between sexually transmitted infections (odds ratio, 1.06; 95% CI, 0.56-2.02) or respiratory infections (odds ratio, 0.88; 95% CI, 00.247-3.21) and stroke diagnosis in adjusted models. Subgroup analyses stratified by the presence/severity of HDP showed an effect of infection in all 3 groups, although the effects were not statistically significant in the individual groups.
Among cases, there were 90 diagnoses of ischemic stroke (19.8%), 60 of subarachnoid hemorrhage (13.2%), 58 of intracerebral hemorrhage (12.8%), 3 of venous sinus thrombosis (0.66%), and 244 diagnoses of unspecified pregnancy-related stroke (53.6%). Among cases that had a pregnancy-specific stroke diagnostic code (n=388) which included a fifth-digit modifier for timing, 275 (70.9%) of strokes occurred before delivery, and 113 (29.1%) occurred after delivery. Discharge disposition data were incomplete; however, among the available records, a lower proportion of cases than controls were discharged home after delivery (258 of 455 cases [76.8%] Women with gestational hypertension or mild preeclampsia were considered to have mild HDP. Women with severe preeclampsia or eclampsia were considered to have severe HDP. CI indicates confidence interval; HDP, hypertensive disorder of pregnancy; and OR, odds ratio.
*Adjusted models included only those variables found to be associated both with the primary exposure (infection) and the outcome (stroke diagnosis code); these were race/ethnicity and payer status. 
Discussion
Infection has emerged as an important risk factor and precipitant for stroke, 24 particularly in younger patients, but has not been extensively studied as a stroke risk factor within a pregnant population. In our analysis of 3 large statewide administrative data sets, we found that infections present on admission, particularly genitourinary infections and sepsis, increased the risk of stroke diagnosis during delivery admission, even when matched on presence and severity of HDP. We previously showed that infections, especially genitourinary, raised the risk of pregnancy-related stroke in women with preeclampsia. 15 However, this association has not been previously described in the general pregnant population, and the timing of infections in relation to stroke diagnosis in this population has not been explored.
Infection has been described as a stroke trigger, 10, 25 with proposed mechanisms including increased platelet aggregation because of systemic inflammation, endothelial dysfunction, infection-induced cardiac arrhythmias, and dehydrationrelated thrombosis. 26 Infections can also directly cause strokes, such as in the case of infectious arteriopathies or septic emboli from infectious endocarditis. 27 Pregnancy is known to alter immune system function and increase the severity of certain infections, such as influenza 28 ; whether pregnant women are more vulnerable to contracting infections is debated. 29 However, pregnant women do seem to have an enhanced inflammatory response to infections, particularly toward the end of pregnancy. 30 It is plausible that this enhanced inflammatory response could play a role in increasing the risk of peripartum stroke. This is supported by our finding of a markedly higher risk of peripartum stroke in women with sepsis, which could be because of a dose-response to high levels of systemic inflammation. Another possibility is that treatment of infection, rather than infections themselves, was associated with stroke; however, we were unable to determine medication effects, as medications are not tracked in billing data.
An association between infections and peripartum stroke has important implications for clinical management. Guidelines for preventing infection in pregnancy and the puerperium recommend against routine antibiotic prophylaxis in the second and third trimester. 31 Current evidence does not support routine prophylaxis of infection after vaginal delivery. 32 However, various antibiotic strategies have been used for the prevention of postoperative infections in women undergoing cesarean delivery, [33] [34] [35] which was highly prevalent among the cases in our study (likely because of the high proportion of HDP). Universal adoption of evidence-based practices aimed at infection prevention may have a side benefit of reducing the risk of stroke. Of note, genitourinary infections showed a higher risk than infections overall in our study; these infections are common during pregnancy and can be easily screened for and treated. 36 Whether routine antibiotic prophylaxis could reduce the risk of peripartum stroke in selected high-risk individuals is not known and is difficult to test in a clinical trial because of the rarity of the outcome. However, our results suggest that women identified as having genitourinary infections on admission for delivery might warrant closer monitoring for neurological complications in the peripartum period, regardless of HDP status. Women with sepsis are likely to be admitted to an intensive care unit in any case, but our study reinforces that prompt attention should be given to any new neurological sign or symptom in this vulnerable group.
Strengths of our study include its large size, comprehensive capture of delivery admissions in the states sampled, and geographic, racial, and ethnic diversity. Matching by the presence and severity of HDP removed a potential confounding factor because preeclampsia and related conditions are associated with both infections and peripartum stroke. Furthermore, restricting our exposure of interest to infections present on admission (rather than hospital acquired) reduces the likelihood that these infections could be a complication of stroke rather than a risk factor.
Our study has important limitations. First, administrative data sets are prone to coding errors, leading to possible overor underestimation of stroke diagnoses. Although the traditional stroke diagnostic codes we used have been shown to have high sensitivity, specificity, and positive predictive value in rigorous validation studies, 37 questions have been raised about the accuracy of pregnancy-specific stroke diagnostic codes (ICD-9 674.0x) 38 ; however, these codes have been used in many prior administrative database studies, 8, 16, [39] [40] [41] and at our own institution, we found the 674.0x codes to have a positive predictive value of 80.4%. 15 Furthermore, the cumulative incidence of stroke diagnoses during delivery hospitalization in our sample was 16.3 per 100 000 deliveries, a rate which is consistent with a recent meta-analysis showing the overall incidence of pregnancy-associated stroke (including antepartum, delivery, and postpartum admissions) to be 30 per 100 000 deliveries. 1 Second, some women may have been misclassified in terms of presence and severity of HDP; however, these diagnostic codes have been shown to have 94.5% positive predictive value when coded during inpatient hospitalizations. 42 The potential of misclassification for infection identification is an additional limitation. Diagnostic codes we used for infections have variable sensitivity and specificity. 43 In an effort to mitigate the limitations of ICD-9 code use for detecting infections, algorithms, multiple ICD-9 codes, and combinations of ICD-9 codes are effective ways of identifying an infection from administrative data. We recognize that this could influence the sensitivity and specificity of infection diagnosis; however, the misclassification in the identification of infections through these methods would be nondifferential and would bias our results toward the null. Also, we were unable to assess for medications such as antibiotic use, which could have affected the risk of stroke. Last, pregnancy-specific stroke codes specify timing of the stroke (before, during, or after delivery) but do not specify stroke subtype (ischemic versus hemorrhagic); conversely, nonpregnancy-specific codes can better characterize stroke subtype but provide no information on timing in relation to delivery. These limitations, common to most large administrative data set-based studies, highlight the need for prospective studies of pregnancy cohorts 44 to meticulously track maternal neurological outcomes, both during the delivery admission and postpartum. Our results should be interpreted with caution and viewed as exploratory and hypothesis generating.
Conclusions
Infections present on admission increased risk of stroke diagnosis during delivery admissions in women with and without HDP. The results were driven by genitourinary infections and sepsis, which were associated with considerably higher risk than infections overall. Infections may be an underrecognized precipitant of peripartum stroke. 
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